The store will not work correctly when cookies are disabled.
6-fluoro-2-(4-(trifluoromethyl)phenyl)-4H-thiochromen-4-one 1,1-dioxide
ID: ALA5177826
PubChem CID: 162538689
Max Phase: Preclinical
Molecular Formula: C16H8F4O3S
Molecular Weight: 356.30
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1C=C(c2ccc(C(F)(F)F)cc2)S(=O)(=O)c2ccc(F)cc21
Standard InChI: InChI=1S/C16H8F4O3S/c17-11-5-6-14-12(7-11)13(21)8-15(24(14,22)23)9-1-3-10(4-2-9)16(18,19)20/h1-8H
Standard InChI Key: UNGRGOXVSCHUCG-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
-2.8559 1.0310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1413 1.4433 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4294 1.0314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4294 0.2062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1396 -0.2055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8559 0.2025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5706 1.4436 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-0.7148 1.4440 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0001 1.0314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0001 0.2062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7148 -0.2063 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-0.7148 2.2692 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.7144 -0.2063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4292 0.2060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1413 -0.2059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1413 -1.0314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4310 -1.4432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7144 -1.0351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8559 -1.4439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5706 -1.0314 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.8559 -2.2692 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.5706 -1.8565 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-1.1281 -0.9223 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.3030 -0.9223 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
1 7 1 0
3 8 1 0
9 8 1 0
10 9 2 0
11 10 1 0
4 11 1 0
8 12 2 0
13 10 1 0
14 13 2 0
15 14 1 0
16 15 2 0
17 16 1 0
13 18 1 0
18 17 2 0
16 19 1 0
19 20 1 0
19 21 1 0
19 22 1 0
11 23 2 0
11 24 2 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 356.30 | Molecular Weight (Monoisotopic): 356.0130 | AlogP: 3.86 | #Rotatable Bonds: 1 |
Polar Surface Area: 51.21 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.44 | CX LogD: 3.44 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.58 | Np Likeness Score: -0.85 |
References
1. Gupta O, Pradhan T, Bhatia R, Monga V.. (2021) Recent advancements in anti-leishmanial research: Synthetic strategies and structural activity relationships., 223 [PMID:34171661] [10.1016/j.ejmech.2021.113606] |